NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/09/2025
Voltar para busca
Dado oficial do USPTO
CLINICAL DATA STUDIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
CLINICAL DATA STUDIO
ST13
US500000098837989Classe
42
Pedido
98837989
Registro
7934553
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
16
Atualização mais recente
10/09/2025
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
05/11/2024
Data de registro
09/09/2025
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/09/2025
Última transação
10/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
18/06/2024
Primeiro uso no comércio
18/06/2024
Código do desenho
4
Tipo de titular
03
Localização do titular
New York, NY
Examinador
NGUYEN, CINDY
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Medidata Solutions, Inc.
Representantes
Jordan A. LaVine Flaster Greenberg PC
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Cloud computing featuring software for use managinggatheringorganizingsharing datainformation and images in the fields of medical clinical trials and medical researchfor the collection of information and data in medical clinical trials and medical researchfor evaluating and measuring the performance and results of medical clinical trials and medical researchfor medical clinical trial and medical research user and learning managementfor medical clinical trial and medical research operational reporting and analytics; Compiling data for research purposes in the field of medical science and medical consultancy; Medical research; Providing an on-line searchable database in the field of medical clinical trials and medical research for scientific research purposes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the field of clinical trials; Research and development and consultation related thereto in the field of of clinical trials; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for managinggatheringorganizingsharing datainformation and images in the fields of medical clinical trials and medical researchfor the collection of information and data in medical clinical trials and medical researchfor evaluating and measuring the performance and results of medical clinical trials and medical researchfor medical clinical trial and medical research user and learning managementfor medical clinical trial and medical research operational reporting and analytics; Software as a service (SAAS) services featuring software for managinggatheringorganizingsharing datainformation and images in the fields of medical clinical trials and medical researchfor the collection of information and data in medical clinical trials and medical researchfor evaluating and measuring the performance and results of medical clinical trials and medical researchfor medical clinical trial and medical research user and learning managementfor medical clinical trial and medical research operational reporting and analytics
Publicações
Histórico de despachos e eventos da marca no USPTO.
16 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
09/09/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/07/2025
PUBO
PUBLISHED FOR OPPOSITION
22/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/07/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/06/2025
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
10/04/2025
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
10/04/2025
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
10/04/2025
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
10/04/2025
DOCK
ASSIGNED TO EXAMINER
26/03/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/11/2024
NWAP
NEW APPLICATION ENTERED
05/11/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CLINICAL DATA STUDIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.